Logiscreen

Ascendis Pharma A/S

$210.45
Market Cap 12.92B
ROE -5435.6%
Gross Margin 92.9%
Debt/Equity 1.8
Current Ratio 1.0
Revenue QoQ 144.3%
EPS QoQ -7.5%
F-Score 3

About

Ascendis Pharma is applying its innovative TransCon technology platform to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by its core values of Patients, Science, and Passion, Ascendis uses its TransCon technologies to create new and potentially best-in-class therapies. Ascendis is headquartered in Copenhagen, Denmark and has additional facilities in Europe and the United States.

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
23.34
vs median 33.61
P/B
23.72
vs median 2.16
ROE
-54.36
vs median 0.09

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics